Skip to content
Screener
Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$11.58M+548%$1.55M+199%——-$1.93M-407%-$2.59M+15.0%
$1.39M+37.9%$1.13M+11.6%$1.02M+186%$1.01M+263%$1.01M+260%
$1.47M-30.0%$1.52M+26.5%$1.12M+43.7%$1.09M+51.2%$2.1M+150%
$7.26M-8.8%$7.41M+254%——$12.03M+307%$7.96M—
——$75K—$49K+308%$284K—-$0—
————-$0-100%-$0-100%-$0-100%
——-$15.08M—-$49K+99.9%-$284K—$0—
————$0—$0-100%-$0-100%
——$1.39M+253%$421K-98.7%————
$7.18M-9.7%-$6.28M-353%——$11.74M—$7.96M—
$7.26M-8.8%$7.33M+251%——$11.74M+298%$7.96M—

FAQ

How much cash does Eton Pharmaceuticals, Inc. generate?
Eton Pharmaceuticals, Inc. (ETON) generated $34.6M in operating cash flow over the trailing twelve months.
What is Eton Pharmaceuticals, Inc.'s free cash flow?
Eton Pharmaceuticals, Inc.'s free cash flow was $34.3M over the trailing twelve months, up 1065.6% year over year.
Where does Eton Pharmaceuticals, Inc.'s cash flow data come from?
Every line is extracted from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.